Theravance Biopharma TBPH Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $288.1M+71.7% | $167.81M-4.0% | $174.77M-38.0% | $281.93M+155% | $110.61M+193% | ||
| $106.57M-27.8% | $147.55M-4.7% | $154.91M+172% | $56.88M+181% | $20.24M-60.0% | ||
| $417.63M-0.2% | $418.46M+18.0% | $354.7M-3.2% | $366.29M+144% | $150.26M-6.7% | ||
| $5.54M-6.0% | $5.9M-5.8% | $6.26M-5.8% | $6.64M-5.5% | $7.03M-5.3% | ||
| $472.31M-2.7% | $485.57M+16.9% | $415.46M-2.5% | $426.04M+24.0% | $343.58M-3.0% | ||
| $1.1M-57.2% | $2.57M+16.0% | $2.21M+32.1% | $1.68M-30.4% | $2.41M+7.4% | ||
| $31.78M-17.0% | $38.3M+2.4% | $37.41M-31.5% | $54.63M+73.4% | $31.5M-1.8% | ||
| $1K0.0% | $1K— | —— | —— | —— | ||
| -$864.56M-0.6% | -$859.63M+6.6% | -$920.65M+0.4% | -$924.27M+5.6% | -$979.1M-1.4% | ||
| $290.59M-2.1% | $296.72M+27.5% | $232.68M+3.5% | $224.85M+35.5% | $165.98M-5.4% | ||
| $472.31M-2.7% | $485.57M+16.9% | $415.46M-2.5% | $426.04M+24.0% | $343.58M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Theravance Biopharma's total assets?
- Theravance Biopharma (TBPH) holds $472.3M in total assets, up 37.5% year over year.
- How much debt does Theravance Biopharma have?
- Theravance Biopharma carries $40.5M in total debt against $290.6M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Theravance Biopharma have?
- Theravance Biopharma holds $288.1M in cash and equivalents.
- Can Theravance Biopharma cover its short-term obligations?
- Its current ratio is 13.14 — current assets exceed current liabilities.
- Where does Theravance Biopharma's balance sheet data come from?
- Every line is extracted from Theravance Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
